Analysis of the effect of perioperative Urovaxom medication for the prevention of postoperative febrile urinary tract infection after ureteroscopic lithotripsy

Efficacy of Urovaxom to prevent postoperative febrile urinary tract infection for ureteroscopic ureterolithotomy in patients with previous urinary tract infection: prospective randomized study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0006991

Enrollment

192

Registered

2022-02-10

Start date

2022-01-24

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The patients who had history of previous urinary tract infection and are planned to undergo ureteroscopic lithotripsy will be randomized. The patients who are in the Urovaxom medication group w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? A patient with previous urinary tract infection and planned to undergo ureteroscopic lithotripsy for kidney or ureter stone less than 2cm ? A patient who were given informed consent voluntarily

Exclusion criteria

Exclusion criteria: ? A patient with currently uncontrolled active urinary tract infection ? A patient with bilateral urinary stones ? A patient with pre-operative indwelling ureteral stent or percutaneous nephrostomy catheter ? An immunocompromised patient ? Pregnant woman ? A patient with urogenital anomaly, such as ureteral stricture ? A patient with previous adverse event of Urovaxom

Design outcomes

Primary

Measure	Time frame
Incidence of post-operative urinary tract infection after ureteroscopic lithotripsy;Incidence of post-operative asymptomatic bacteriuria	—

Secondary

Measure	Time frame
Incidence rate of post-operative sepsis or systemic inflammatory response syndrome;Type of antibiotics usage in case of post-operative urinary tract infection;Duration of antibiotics usage in case of post-operative urinary tract infection	—

Countries

Korea, Republic of

Contacts

Public ContactBum Soo Kim

Kyungpook National University Hospital

dock97@hanmail.net+82-53-200-5855

Outcome results